A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

Locations

Not recruiting

Start date

14/06/2024

Identifiers

Trial ID NN9487-7612,
NCT number NCT06461039,
Eudract number Not Available

Summary

This study medicine NNC0487-0111 to improve the treatment options for people living with overweight and obesity or with type 2 diabetes. The purpose of the study is to investigate if NNC0487-0111 affects how effective birth control pills are. Participants will take 1-tablet once daily. The study medicine will taken orally for 18 weeks and then study medicine will be injected with a thin needle in a skin fold in the abdomen for 9 weeks.The study will last for about 35 weeks.

Trial Overview:

Condition

Obesity

Treatment

DRUG: NNC0487-0111 A

DRUG: NNC0487-0111 C

DRUG: Levonorgestrel 150 μg + Ethinylestradiol 30 μg (Oral contraceptive OC)

DRUG: Acetaminophen - 500 mg/15 ml

Study type

INTERVENTIONAL

Trial duration

Jun 14 2024 - Apr 07 2025

Participants

Phase

Are you eligible?

Gender

FEMALE

Age

18 to 65 years old

Find out how you can participate

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

Find answers in our FAQs

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.